CSS
GNMK

Cubist Systematic Strategies’s GenMark Diagnostics, Inc GNMK Stock Holding History

Cubist Systematic Strategies’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-53,940
Closed -$788K – 3043
2020
Q4 		$788K Sell
53,940
-65,896
-55% -$873K 0.01% 1524
2020
Q3 		$1.7M Sell
119,836
-174,509
-59% -$2.67M 0.03% 1002
2020
Q2 		$4.33M Buy
+294,345
New +$2.99M 0.07% 412
2020
Q1 		– Sell
-638
Closed -$3K – 2606
2019
Q4 		$3K Sell
638
-14,011
-96% -$77.3K ﹤0.01% 2384
2019
Q3 		$89K Sell
14,649
-9,294
-39% -$58K ﹤0.01% 1960
2019
Q2 		$155K Sell
23,943
-22,334
-48% -$157K ﹤0.01% 2142
2019
Q1 		$328K Buy
+46,277
New +$305K 0.01% 1450
2017
Q3 		– Sell
-6,454
Closed -$76K – 2076
2017
Q2 		$76K Buy
+6,454
New +$82.5K ﹤0.01% 1493

Other funds holding GNMK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cubist Systematic Strategies's GNMK Position: Q1 2021 in Review

Cubist Systematic Strategies sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 53,940 shares — an estimated $788K sold.

Cubist Systematic Strategies first reported a position in GNMK in Q2 2017 and held it in 8 quarters. The position peaked at $4.33M in Q2 2020. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • Cubist Systematic Strategies reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • Cubist Systematic Strategies sold 53,940 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $788K.
  • Cubist Systematic Strategies first reported a position in GenMark Diagnostics, Inc in Q2 2017 and held it in 8 quarters.
  • Cubist Systematic Strategies's GenMark Diagnostics, Inc position peaked at $4.33M in Q2 2020.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Cubist Systematic Strategies's 13F filing for Q1 2021, filed 17 May 2021.